Loading data for ANAB — first visit, this takes a few seconds.
AnaptysBio Inc. (ANAB)
NasdaqGS: ANAB
· Real-Time Price · USD
56.28
-1.01 (-1.76%)
At close: Aug 28, 2026, 8:00 PM
56.28
+0.00%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
AnaptysBio Inc. (ANAB) Stock Price, Analysis & Data
-1.76% (1D)
No data available
| Bid | 45 |
| Market Cap | 1.67B |
| Revenue (ttm) | 232.39M |
| Net Income (ttm) | -26.79M |
| 0.40 | |
| -1 | |
| n/a | |
| 12.92 | |
| P/B (ttm) | 128.20 |
| P/S (ttm) | 7.17 |
| Earnings Date | Aug 31, 2026 |
| Ask | 72 |
| Volume | 358,263 |
| Avg. Volume (20D) | 599,939 |
| Open | 57.10 |
| Previous Close | 57.29 |
| Day's Range | 55.38 - 57.24 |
| 52-Week Range | 11.40 - 72.36 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ANAB
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b trial for celiac disease and eosinophilic esophagitis; A...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 26, 2017
Employees 104
Stock Exchange NasdaqGS
Ticker Symbol ANAB
Website https://www.anaptysbio.com
Financial Performance
In 2025, AnaptysBio's revenue was 234.6M, an increase of 157.01% compared to the previous year's 91.28M. Earnings were -13.23M, a decrease of -90.89%.
Financial StatementsEarnings Surprise
AnaptysBio has released their quarterly earnings on Mar 3, 2026:
- Revenue of $25.56M misses estimates by $0, with -7.98% YoY decline.
- EPS of 1.58 exceeds estimates by 0.65, with 319.44% YoY growth.
AnaptysBio Inc. is scheduled to release its earnings on Aug 31, 2026, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2